ROL vs SER · P/E 41, rev $3.39B vs rev $56.0K
Rollins Inc (ROL) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. SER currently screens at market cap $29.7M.
Not investment advice. Open the ROL and SER stock pages for the full models.
Not investment advice.